Locations:

Cancer

22-CNR-3344410-CQD-Hero-650×450 Dr Gerds Momentum trial

December 9, 2022/Cancer/Research

Sustained Response Observed in MOMENTUM Trial of Patients with Myelofibrosis

Study matches momelotinib against danazol

December 6, 2022/Cancer

Phase 1 Trial Shows Drug-Resistant Immunotherapy for Glioblastoma Is Safe and Feasible

Intracranial injection of supercharged immune cells proceeds to phase 2 testing

November 30, 2022/Cancer

Case Study: Patient Undergoing Whipple After Liver Transplant

Atypical cells discovered after primary sclerosing colongitis diagnosis

November 28, 2022/Cancer

Infectious Disease Protections for Patients with Cancer

A Q&A with infectious disease expert Eric Cober, MD

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

November 23, 2022/Cancer

Demystifying Palliative Care

Integral support for living well with cancer

November 4, 2022/Cancer/Radiation Oncology

Top Research from ASTRO 2022

Key abstracts highlight advances in treating locally advanced and refractory disease

November 3, 2022/Cancer/Research

High Rates of Breast Cancer Recurrence after Intraoperative Radiation Therapy

Research supports national guidelines for early-stage breast cancer

22-DDI-3150240 Complete mesocolic excision for colon cancer 650×450

November 2, 2022/Cancer

The Case for Complete Mesocolic Excision

Outcome supports procedure’s routine use in colon cancer surgery

November 2, 2022/Cancer/Research

Questions Remain about When to Employ Immunotherapy for Resected High-Risk Melanoma

Timing of adjuvant immunotherapy unclear for maximum overall survival

22-CNR-3290514-CQD-Hero-650×450 lung cancer

October 27, 2022/Cancer/Research

Higher-dose Stereotactic Radiotherapy Achieves Better Control for Many Aggressive Lung Tumors

Treatment decision must be balanced against toxicity concerns

BackPage 15 of 140Next